so what has management told us in the announcements this week...

so what has management told us in the announcements this week



we have 7 anteobind products and now 3 separate CET projects




above from Ewen  "both divisions offer multi-billion-dollar opportunities "



in the CET division we are in ev1's prototype testing.





couldn't be more emphatic than that. also moving ahead with ev2, wyon is dealing with us again and a "development proposal has been provided to a leading consumer electronics battery manufacturer"

also our 70% silicon project is gaining traction. the silicon we are using costs $10/kg compared to Chinese $100/kg and US $2000/kg for their highly refined silicon. add that to the CNT saving and it makes a strong reason for market acceptance. also if ev1's with around 20% silicon using anteoX increases capacity retention by 38%, what will be the performance of our 70% silicon anode? what the market is asking for cost reduction and performance improvement

as well we have added a 3rd CET division cell engineering and electrochemistry. separators and CNT usage.



thats what our nano glue does, stops shrinkage and cracking. if this is successful anteoX revenue opportunity  significantly expands. what battery manufacturer wouldn't want a better performing separator?

then with our lifescience division



SIOI, vidcare, fisheries dept and Korean university and



further opportunities in the Indian healthcare system. the life science division is starting small but as peterfred said a chance of parabolic expansion.

IMO shareholders were given an excellent overview of revenue opportunities, partnership progression and company development. now some more announcements please !!!!!

ps. just to glimpse what some of anteotech's future markets could be. this paper from Hungary was released this week using anteobind. it's a heavy scientific paper but this shows one direction of future of diagnostic testing where anteobind is still in a sweet spot

Optical Interferometric Device for Rapid and Specific Detection of Biological Cells


https://www.mdpi.com/2079-6374/14/9/421

"The sample chamber was filled up with AnteoBindTM Biosensor (AnteoTech, Eight Mile Plains, Queensland, Australia) and incubated for 15 min at room temperature to facilitate antibody binding to the glass surface as a chelator."

anteotech has already opportunities in CET and lifescience but in reality is only scratching the surface of what the future holds for it's supramolecular chemistry

GLTAH.......